SYLVIA NWAKANMA: Open Payments
NPI 1467946178 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,885 in 61 payments from 10 companies in 2025. Trend: 2023 $566 · 2024 $1,094 · 2025 $5,885
Honoraria: $4,000Food & beverage: $1,774Education: $111
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 13 | $4,280 |
| Otsuka America Pharmaceutical, Inc. | 14 | $520 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $506 |
| Teva Pharmaceuticals USA, Inc. | 3 | $160 |
| Lundbeck LLC | 4 | $105 |
| ABBVIE INC. | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Tempus AI, Inc | 2 | $59 |
| Axsome Therapeutics, Inc. | 1 | $30 |
Products named: RELTONE 200 MG, REXULTI, CAPLYTA, VRAYLAR, SPRAVATO, COBENFY, AUSTEDO XR, TEMPUS PIXEL.
Industry payments across TX — which companies pay providers there.
